The National Shingles Vaccination Program was implemented from November 2016. This is the first major new vaccine program introduced for older Australians in more than a decade. The program provides free shingles vaccination, using Zostavax®, to adults aged 70 years, with a catch-up for those aged 71–79 years funded until 2021. The evaluation examined the implementation of the shingles vaccination program and also assessed vaccine coverage and safety data. Feedback from key stakeholders, primary healthcare providers and the public generally found that the program was well-promoted, well-delivered and the vaccine was a popular addition to the vaccination schedule for older Australians. 

Shingles Program Evaluation Report_1 March 2019_Final for web_2.pdf 2019 Immunisation coverage Immunisation reviews Varicella-zoster